DraftKings stock is down 30%, but 2025 profitability and growth prospects make it a compelling buy. Click here to read an ...
The disease under the proposal would receive the same reports that other tick-borne diseases such as Lyme disease currently ...
AlphaQuest LLC boosted its position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) by 16.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange ...
Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here ...
AlphaQuest LLC cut its position in shares of Iradimed Corporation (NASDAQ:IRMD – Free Report) by 74.7% during the fourth ...
Counterpart explores alternate universes with exceptional performances, sharp writing, and philosophical exploration.
Interim results from three trials exploring the use of Alpha DaRT® in treating pancreatic cancer showing high disease control rate, impressive overall survival in sub-group analyses, and positive safe ...
Interim results from three trials exploring the use of Alpha DaRT® in treating pancreatic cancer showing high disease control rate, impressive overall survival in sub-group analyses, and positive safe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results